Lower riskMedical device recall · FDA · Published December 9, 2021
Greiner Bio-One VACUETTE Tubes Recall: Clotting Risk in Blood Collection
Greiner Bio-One recalls 1200 blood collection tubes that may clot due to lithium heparin variation. Affected tubes have green cap with yellow ring. Consumers should check product details and contact for remedy.
“Greiner Bio-One VACUETTE Tubes Recall: Clotting Risk in Blood Collection.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61442-greiner-bio-one-vacuette-tubes-recall-clotting-risk-in-blood. Based on FDA recall #Z-0502-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0502-2022%22&limit=1).
Greiner Bio-One North America, Inc. voluntarily recalled greiner bio-one VACUETTE TUBE blood collection tubes due to potential clotting caused by Lithium Heparin variation, the FDA said on Dec. 9, 2021.
How to tell if you have it
Brand: Greiner Bio-One
Product: greiner bio-one VACUETTE TUBE, 5 ml LH Lithium Heparin Sep, 13x100 green cap-yellow ring, non-ridged, 24 racks of 50
REF: 456087P
Lot #B21053QG
Exp. 09/09/2022
UDI Case: 39120017579046
UDI Rack: 29120017579049
The hazard
Some of the blood collection tubes show clotting due to variation of Lithium Heparin, according to the FDA.
Context
GovInfoNow's records show Greiner Bio-One North America, Inc. has 11 other recalls on record since 2019-11-25. Other recent recalls of similar products include Vacuette 8ml CAT Serum Separator Clot Activator Tubes (2025-08-19), Greiner Bio-One VACUETTE 2ml Coagulation Tubes (2025-08-08), and Greiner Bio-One VACUETTE Tube Recall (2024-05-14).
How to tell if you have this one
Check for green cap with yellow ring, non-ridged tubes, 13x100 pack, 24 racks of 50. Lot number B21053QG and expiration date 09/09/2022 are also indicators.
Brand
Greiner Bio-One
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for green cap with yellow ring, non-ridged tubes, 13x100 pack, 24 racks of 50, lot number B21053QG, and expiration date 09/09/2022.
Where it went and when
Where it was distributed
Distributed in 10 states.
Listed by the agency
Not listed
FDA distribution: “Distribution was made to FL, IL, MO, NC, NM, NY, PA, TN, TX, and VA. There was no foreign/military/government distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, Illinois, Missouri, New Mexico, New York, North Carolina, Pennsylvania, Tennessee, Texas, Virginia.
Recall timeline
FDA terminated this recall 22 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0502-2022 (December 9, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0502-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.